Yemeni Army Chief of Staff to Asharq Al-Awsat: We Are Ready to Decide Battles, Achieve Victory

Bin Aziz was army commanders in Marib. (Saba)
Bin Aziz was army commanders in Marib. (Saba)
TT

Yemeni Army Chief of Staff to Asharq Al-Awsat: We Are Ready to Decide Battles, Achieve Victory

Bin Aziz was army commanders in Marib. (Saba)
Bin Aziz was army commanders in Marib. (Saba)

Yemen Armed Forces Chief of Staff Lt. Gen. Sagheer bin Aziz confirmed that the forces of the legitimate government are fully prepared to decide the battle and achieve victory.

In remarks to Asharq Al-Awsat, he stressed that the formation of the Yemeni Presidential Leadership Council presents a practical transformation and an advanced step towards ending the conflict, stopping the war and restoring state institutions.

“I imagine that the Council, led by Chairman Rashad Al-Alimi and his brother members of the Council, possesses many traits that will allow it to achieve many of the aspirations of the Yemeni people,” bin Aziz said.

He stated that the Council includes political figures with great leadership experience who represent all the active political components in Yemen.

Moreover, he warned the Iran-backed Houthi militias that they had a choice to make, either give up arms and engage in political dialogue or lose to the battle with the army.

“The militias must determine their options, either to lay down their arms and join the dialogue as a political component to come up with solutions that guarantee the return of state institutions, or leave the issue to the army to decide the battle,” he said.

Ever since the UN-sponsored truce went into effect in early April, the Houthis have openly exploited the Saudi-led Arab coalition’s halt of aerial operations by doubling their building of fortifications, digging of trenches and opening secondary roads on various fronts, especially in the oil-rich Marib governorate.

“The Houthis are subject to follow-up and monitoring by international institutions and all humanitarian organizations interested in peace in the world, and I believe that they know the true extent of the commitment of the Iranian-backed terrorist Houthi militia to this truce,” bin Aziz remarked.

In April alone, the Houthis committed 2,700 violations against army positions.

The militias also deployed heavy combat units that include tanks and armored vehicles to front lines. They repositioned missile and drone launchers as well.

“Asharq al-Awsat newspaper publishes dozens of news articles daily about the extent of the militias' infiltrations in the Marib, Al-Jawf, Saada, Hajjah, Hodeidah, Taiz and Dhale fronts,” noted bin Aziz.

He blamed the international community, which, according to him, continues to overlook the unprecedented terrorist acts and crimes committed by the militias.

He spoke against the international community’s acceptance of the blatant Iranian interference in Yemen and its attempts to implement an occupational agenda in the war-torn nation.

“The danger lies in the international community condoning the unprecedented terrorist acts and crimes committed by these militias, and what is more dangerous is its acceptance of the blatant Iranian interference in Yemen,” he said.

He warned that the truce from the militias’ perspective is nothing more than an opportunity to reorganize ranks, mobilize all human, material and armament capabilities, and assume offensive positions in preparation for a wide and surprising attack.

He predicted that the Houthis will focus their combat effort on major fronts, especially Marib.

However, bin Aziz underscored the readiness of the Yemeni army, popular resistance forces and tribesmen in repelling any Houthi aggression with the support of the Arab coalition.

“Our national army and with it the heroes in the popular resistance and tribesmen and all who support the legitimate government believe in the justice of defending the dignity and freedom of Yemen and Yemenis,” he asserted.

“Their historically proven courage, and their great combat experience gained in the eight years of battles, make them more able to defeat Houthi militias,” vowed bin Aziz.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.